Hologic Inc (BSP:H1OL34)
R$ 447.04 0 (0%) Market Cap: 101.45 Bil Enterprise Value: 103.43 Bil PE Ratio: 22.62 PB Ratio: 3.40 GF Score: 86/100

Hologic Inc at Jefferies Healthcare Conference Transcript

Jun 04, 2019 / 07:00PM GMT
Rajbir Singh Denhoy
Jefferies LLC, Research Division - MD, Equity Research & Senior Equity Research Analyst

Thanks, everyone, again, for joining us here at the Jefferies Healthcare Conference 2019. Up next we have Hologic. From the company we have Mike Watts, Investor Relations, in the audience. And from the company we have Karleen Oberton, the company's CFO to tell us a story. So Karleen, I'll turn it over to you.

Karleen M. Oberton
Hologic, Inc. - CFO

Thank you, Raj, and thank you, folks, for joining us here today to learn a little more about Hologic. So forward-looking statements might be made and here are safe harbor statement in regards to that. Non-GAAP financial measures will be talked about.

So Hologic, we have been on a turnaround -- if we look back the last 5 years, a turnaround and now are in sustainable growth. And the turnaround has been broad-based. It's been, at the leadership level, it's been commercial capabilities, it's been diligent focus in our R&D pipeline, it's building our international capabilities in regards to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot